Press Release Distribution
Pricing
Customer Support
(800) 998-2927
Login
Log In
All Categories
Business
Entertainment
Health
Finance
Other
Tagged
solid-tumours
Press Release
Mar 10, 2020
Syndivia Receives €2m Deeptech Financing From Bpifrance to Advance Its Lead Immunoconjugate for Solid Cancers
Read More
Press Release
Jan 16, 2020
Syndivia In-Licenses Novel Antibody Against Tumor-Specific Form of CD146 From SATT Sud-Est
Syndivia receives the exclusive sublicense specifically for immunoconjugates of the monoclonal antibody against the tumor-specific form of CD146 (CD146-ts mAb), which represents a first-in-class opportunity for the treatment of a number of solid cancers, including melanoma and pancreatic cancer.
Read More
Press Release
Dec 10, 2019
Syndivia Raises €1M Investment to Advance Its Tumour Microenvironment Drug Delivery Platform
Read More
First
Prev
1
Next
Last
